Skip to Main Content

Author Details

Zejuan Li
Houston Methodist Hospital
2005
57
35
PMIDPaper TitleJournal TitlePublished Year
37372359Classification of Acute Myeloid Leukemia by Cell-Free DNA 5-Hydroxymethylcytosine.Genes (Basel)2023
37620919Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemia.Clin Epigenetics2023
37541212TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal.Cell Stem Cell2023
35859008Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia.Sci Rep2022
35613340Exome sequencing identifies PD-L2 as a potential predisposition gene for lymphoma.Hematol Oncol2022
33054462Identifying possible germline variants from tumor-only sequencing of hematological malignancies.Leuk Lymphoma2021
33510405Germline variants drive myelodysplastic syndrome in young adults.Leukemia2021
33434505R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m<sup>6</sup>A/PFKP/LDHB axis.Mol Cell2021
32531268Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.Cancer Cell2020
32734171Development and validation of Houston Methodist Variant Viewer version 3: updates to our application for interpretation of next-generation sequencing data.JAMIA Open2020
31101556Somatic mutation panels: Time to clear their names.Cancer Genet2019
31648317ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.Blood Adv2019
29915382Targeted exome analysis identifies the genetic basis of disease in over 50% of patients with a wide range of ataxia-related phenotypes.Genet Med2019
29344583Heterozygous <i>RTEL1</i> variants in bone marrow failure and myeloid neoplasms.Blood Adv2018
30113886Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.J Clin Oncol2018
29633759Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.Nat Commun2018
29686311RNA N<sup>6</sup>-methyladenosine modification in cancers: current status and perspectives.Cell Res2018
29365323Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.Blood Adv2018
29279609Molecular characterization of HDAC8 deletions in individuals with atypical Cornelia de Lange syndrome.J Hum Genet2018
28017614FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N<sup>6</sup>-Methyladenosine RNA Demethylase.Cancer Cell2017
26894574Improved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach.J Pediatr Endocrinol Metab2016
27116251miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia.Nat Commun2016
27280396Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles.Cancer Res2016
26747896PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.Cancer Res2016
26791235Identification of MLL-fusion/MYCâ¿£miR-26â¿£TET1 signaling circuit in MLL-rearranged leukemia.Cancer Lett2016
25098428RCSD1-ABL2 fusion resulting from a complex chromosomal rearrangement in high-risk B-cell acute lymphoblastic leukemia.Leuk Lymphoma2015
26361793Overexpression and knockout of miR-126 both promote leukemogenesis.Blood2015
25704023TRAIL pathway is associated with inhibition of colon cancer by protopanaxadiol.J Pharmacol Sci2015
25809939A novel mutation in the promoter of RARS2 causes pontocerebellar hypoplasia in two siblings.J Hum Genet2015
24835587The dynamics of DNA methylation fidelity during mouse embryonic stem cell self-renewal and differentiation.Genome Res2014
24842373Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML.J Exp Med2014
23264595PBX3 is an important cofactor of HOXA9 in leukemogenesis.Blood2013
23818607TET1 plays an essential oncogenic role in MLL-rearranged leukemia.Proc Natl Acad Sci U S A2013
23798388miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia.Proc Natl Acad Sci U S A2013
23382473Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study.J Clin Oncol2013
23434653Compound K, a Ginsenoside Metabolite, Inhibits Colon Cancer Growth via Multiple Pathways Including p53-p21 Interactions.Int J Mol Sci2013
22353710miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.Nat Commun2012
23730200Crosstalk Between DNA and Histones: Tet's New Role in Embryonic Stem Cells.Curr Genomics2012
23079661Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.Cancer Cell2012
23132946MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia.Proc Natl Acad Sci U S A2012
22633751Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia.Blood Cells Mol Dis2012
22251480Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.Blood2012
22238379Young intragenic miRNAs are less coexpressed with host genes than old ones: implications of miRNA-host gene coevolution.Nucleic Acids Res2012
20931398In vitro functional study of miR-126 in leukemia.Methods Mol Biol2011
21496004MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML.Br J Haematol2011
20110180MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.Blood Cells Mol Dis2010
20133587Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia.Proc Natl Acad Sci U S A2010
19155294Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias.Cancer Res2009
18794849miR-21 plays a pivotal role in gastric cancer pathogenesis and progression.Lab Invest2008
18832181Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.Proc Natl Acad Sci U S A2008
  • 1 - 50 of 57

Recommended Authors

Alex Murison
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2012
Number of shared co-authors 1
Hiroko Tanaka
Tokyo Medical and Dental University
Career Start Year 2012
Number of shared co-authors 7
Ann-Kathrin Eisfeld
The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 0
Tamara L Lamprecht
St. Jude Children's Research Hospital
Career Start Year 2010
Number of shared co-authors 3
Amit U Sinha
Memorial Sloan Kettering Cancer Center
Career Start Year 2007
Number of shared co-authors 1
Su Ming Sun
Leiden University Medical Center
Career Start Year 2006
Number of shared co-authors 1
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 1
Henry Yang
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 4
Richard Koche
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 2
Aniruddha J Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2004
Number of shared co-authors 2
Ji Zhang
Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Rhonda E Ries
Clinical Research Division, Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 3
Jacqueline E Payton
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 0
Yonghong Wang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 0
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 10
Francine E Garrett-Bakelman
University of Virginia
Career Start Year 1999
Number of shared co-authors 1
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 0
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 0
Shinichiro Takahashi
Tohoku Medical and Pharmaceutical University Hospital.
Career Start Year 1998
Number of shared co-authors 0
Kolja Eppert
McGill University
Career Start Year 1996
Number of shared co-authors 2
Brian J P Huntly
University of Cambridge
Career Start Year 1996
Number of shared co-authors 4
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 11
Kimberly Stegmaier
Dana-Farber Cancer Institute
Career Start Year 1995
Number of shared co-authors 3
Mar??a D Odero
University of Navarra
Career Start Year 1994
Number of shared co-authors 2
Seishi Ogawa
Kyoto University
Career Start Year 1993
Number of shared co-authors 10
Timothy A Graubert
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 5
Derek L Stirewalt
Fred Hutchinson Cancer Center
Career Start Year 1992
Number of shared co-authors 2
Scott A Armstrong
Boston Children's Hospital
Career Start Year 1990
Number of shared co-authors 3
Guy Sauvageau
Universite de Montreal
Career Start Year 1988
Number of shared co-authors 0
Christoph Plass
German Cancer Research Center
Career Start Year 1982
Number of shared co-authors 0

Collaborators

Hao Huang
Co-authored papers 18
Abdel G Elkahloun
National Human Genome Research Institute
Co-authored papers 12
Chuan He
Institute of Hematology, West China Hospital of Sichuan University
Co-authored papers 9
Jun Lu
Yale University
Co-authored papers 6
Shenglai Li
Co-authored papers 6
Lucy A Godley
The University of Chicago
Co-authored papers 4
Chong-Zhi Wang
Co-authored papers 3
Simone Feurstein
University Hospital Heidelberg
Co-authored papers 3
Chun-Su Yuan
Co-authored papers 3
Miao Yu
Co-authored papers 2
Gordana Raca
Children's Hospital Los Angeles
Co-authored papers 2
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers 2
Hao Zhang
Co-authored papers 2
Siob??n B Keel
University of Washington School of Medicine
Co-authored papers 2
Sabah Kadri
Abbvie Inc., Genomics Research Center
Co-authored papers 2
Yves A Lussier
Center for Biomedical Informatics and Biostatistics, University of Arizona
Co-authored papers 1
Liying Zhang
The Fifth Affiliated Hospital, Sun Yat-sen University
Co-authored papers 1
David Wu
University of Washington
Co-authored papers 1
Ian D Krantz
Children's Hospital of Philadelphia
Co-authored papers 1
Christopher C Porter
Emory University School of Medicine
Co-authored papers 1
Jun Qi
Dana-Farber Cancer Institute
Co-authored papers 1
Johanna Ten Hoeve
California Nanosystems Institute, University of California los angeles
Co-authored papers 1
Dong-Er Zhang
Moores Cancer Center, University of California San Diego
Co-authored papers 1
Neal S Young
National Heart Lung and Blood Institute Division of Intramural Research
Co-authored papers 1
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Mary-Claire King
University of Washington
Co-authored papers 1
Kym M Boycott
Children's Hospital of Eastern Ontario
Co-authored papers 1
Michael Chicka
Co-authored papers 1
Mark J Routbort
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Wei Wei
Co-authored papers 1
Release 1.2